Trauma-Informed Care + Community Health Workers for Chronic Kidney Disease
(SUPPORT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve kidney care for Black and Hispanic individuals who face higher risks and barriers in accessing treatment. It tests whether community health workers (local helpers trained to support patients) and trauma-informed care (care that considers past trauma) can enhance the lives of those with chronic kidney disease (CKD). Individuals with stage 4 or 5 CKD living in low-income areas of Philadelphia and who are on Medicaid or uninsured might qualify. The trial will compare usual care to two new approaches, including the IMPaCT Community Health Worker Program, to determine which best enhances quality of life and reduces hospital visits.
As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches in kidney care that could benefit the community.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the IMPaCT Community Health Worker Program is well-received by participants. Studies have found that community health workers (CHWs) help patients access necessary healthcare services. For instance, one study found that 69% of participants with abnormal test results sought further medical help with CHW support. This suggests that the program is both safe and effective in aiding patients' healthcare decisions.
In contrast, trauma-informed care (TIC) considers the whole person, including past traumas and current symptoms, aiming to create a safe and supportive environment. Reports have not indicated any negative effects from this method, making it a promising option for managing chronic kidney disease (CKD). Overall, both the CHW program and TIC are considered safe for use in healthcare settings.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to managing chronic kidney disease by integrating trauma-informed care with support from community health workers (CHWs). Unlike traditional treatments that focus solely on medical management, this trial emphasizes the holistic support that CHWs can provide, which includes addressing social and emotional factors that may impact a patient's health. The CHW + TIC arm combines this support with trauma-informed care, which trains clinicians to better understand and respond to patients' trauma histories, potentially improving patient engagement and outcomes. This innovative approach aims to enhance the overall care experience, making it more personalized and supportive, which could lead to better management of the condition.
What evidence suggests that this trial's treatments could be effective for chronic kidney disease?
Studies have shown that Community Health Workers (CHWs) can improve health by providing education and support, particularly for underserved groups. In this trial, one arm includes the Penn Medicine IMPaCT CHW program, a proven method that involves local community members in healthcare to remove obstacles and enhance care for marginalized patients. Research indicates that this program can increase understanding of chronic kidney disease (CKD) and improve patients' quality of life. Another arm focuses on Trauma-Informed Care (TIC), which emphasizes understanding and supporting patients who may have experienced trauma, potentially leading to better health outcomes. With TIC, healthcare providers are better prepared to meet their patients' unique needs, potentially reducing hospital visits and increasing patient involvement. Additionally, one arm combines both CHW and TIC interventions to assess their combined impact.34678
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic individuals with stage 4 or 5 chronic kidney disease, who are Medicaid-eligible or uninsured, living in high poverty areas of Philadelphia. It aims to improve care quality by addressing structural racism and psychological trauma.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 6 months of support from a community health worker and trauma-informed care training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- IMPaCT Community Health Worker Program
- Trauma-Informed Care Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor